查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387681

2024 年癌症诊断全球市场报告

Cancer Diagnostics Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

2023 年癌症诊断市场最大的地区将是北美。亚太地区是全球癌症诊断市场的第二大地区。癌症诊断市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。

目录

第1章执行摘要

第2章癌症诊断市场特点

第3章癌症诊断市场趋势与策略

第4章癌症诊断市场－宏观经济情景

第5章全球癌症诊断市场规模与成长

  • 全球癌症诊断市场的驱动因素与阻碍因素
    • 市场驱动力
    • 市场抑制因素
  • 2018-2023年全球癌症诊断市场规模实绩与成长
  • 2023-2028年至2033年全球癌症诊断市场规模与成长预测

第6章癌症诊断市场区隔

  • 全球癌症诊断市场，按产品、实绩和预测细分，2018-2023、2023-2028、直至 2033 年
  • 伴同性诊断
  • 分子诊断
  • 全球癌症诊断市场，依方法、实绩及预测细分，2018-2023、2023-2028、至 2033 年
  • 切片检查
  • 内视镜
  • 肿瘤生物标记检测
  • 影像
  • 全球癌症诊断市场，按应用、实绩和预测细分，2018-2023、2023-2028、直至 2033 年
  • 子宫颈癌
  • 乳癌
  • 肝癌
  • 血癌
  • 肾癌
  • 大肠直肠癌
  • 胰臟癌
  • 卵巢癌
  • 黑色素瘤
  • 其他用途
  • 全球癌症诊断市场，按最终用户细分、实绩和预测，2018-2023、2023-2028、直至 2033 年
  • 癌症研究所
  • 诊断实验室
  • 医院
  • 其他最终用户

第7章癌症诊断市场区域与国家分析

  • 全球癌症诊断市场，按地区、实绩及预测，2018-2023、2023-2028、至 2033 年
  • 全球癌症诊断市场，依国家、实绩及预测，2018-2023年、2023-2028年至2033年

第8章亚太癌症诊断市场

  • 亚太地区癌症诊断市场概况
  • 区域资讯、COVID-19 影响、市场资讯、背景资讯、政府配合措施、法规、监管机构、关键机构、课税、公司税务结构、投资、主要企业
  • 亚太地区癌症诊断市场，依产品、实绩及预测细分，2018-2023、2023-2028、至 2033 年
  • 亚太地区癌症诊断市场，按应用细分、实绩和预测，2018-2023、2023-2028、直至 2033 年
  • 亚太地区癌症诊断市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、直至 2033 年

第9章中国癌症诊断市场

  • 中国癌症诊断市场概况
  • 中国癌症诊断市场，依产品、实绩及预测细分，2018-2023年、2023-2028年、至2033年
  • 中国癌症诊断市场，按应用细分、实绩和预测，2018-2023年、2023-2028年、直至2033年
  • 中国癌症诊断市场，按最终用户细分，实绩和预测，2018-2023年、2023-2028年、直至2033年

第10章印度癌症诊断市场

  • 印度癌症诊断市场，按产品、实绩和预测细分，2018-2023 年、2023-2028 年、直至 2033 年
  • 印度癌症诊断市场，按应用、实绩和预测细分，2018-2023、2023-2028、直至 2033 年
  • 印度癌症诊断市场，按最终用户细分、实绩和预测，2018-2023、2023-2028、直至 2033 年

第11章日本癌症诊断市场

  • 日本癌症诊断市场，按产品、实绩和预测细分，2018-2023 年、2023-2028 年，直至 2033 年
  • 日本癌症诊断市场，按应用细分、实绩和预测，2018-2023、2023-2028，直至 2033 年
  • 日本癌症诊断市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、直至 2033 年

第12章澳洲癌症诊断市场

  • 澳洲癌症诊断市场，按产品、实绩和预测细分，2018-2023 年、2023-2028 年、直至 2033 年
  • 澳洲癌症诊断市场，按应用细分、实绩和预测，2018-2023、2023-2028、直至 2033 年
  • 澳洲癌症诊断市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、直至 2033 年

第13章印尼癌症诊断市场

  • 印尼癌症诊断市场，按产品、实绩和预测细分，2018-2023 年、2023-2028 年，直至 2033 年
  • 印尼癌症诊断市场，按应用、实绩和预测细分，2018-2023 年、2023-2028 年，直至 2033 年
  • 印尼癌症诊断市场，按最终用户细分，实绩和预测，2018-2023 年、2023-2028 年，直至 2033 年

第14章韩国癌症诊断市场

  • 韩国癌症诊断市场，按产品细分、实绩和预测，2018-2023、2023-2028、直至 2033 年
  • 韩国癌症诊断市场，按应用、实绩和预测细分，2018-2023、2023-2028、直至 2033 年
  • 韩国癌症诊断市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、直至 2033 年

第15章西欧癌症诊断市场

  • 西欧癌症诊断市场概况
  • 西欧癌症诊断市场，按产品细分、实绩和预测，2018-2023、2023-2028、直至 2033 年
  • 西欧癌症诊断市场，按应用细分、实绩和预测，2018-2023、2023-2028、直至 2033 年
  • 西欧癌症诊断市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、直至 2033 年

第16章英国癌症诊断市场

  • 英国癌症诊断市场，按产品细分，实绩和预测，2018-2023、2023-2028、直至 2033 年
  • 英国癌症诊断市场，按应用、实绩和预测细分，2018-2023、2023-2028、直至 2033 年
  • 英国癌症诊断市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、直至 2033 年

第17章德国癌症诊断市场

  • 德国癌症诊断市场，按产品、实绩和预测细分，2018-2023 年、2023-2028 年，直至 2033 年
  • 德国癌症诊断市场，按应用细分、实绩和预测，2018-2023、2023-2028、直至 2033 年
  • 德国癌症诊断市场，按最终用户细分、实绩和预测，2018-2023、2023-2028、直至 2033 年

第18章法国癌症诊断市场

  • 法国癌症诊断市场，按产品、实绩和预测细分，2018-2023 年、2023-2028 年，直至 2033 年
  • 法国癌症诊断市场，按应用、实绩和预测细分，2018-2023 年、2023-2028 年，直至 2033 年
  • 法国癌症诊断市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、直至 2033 年

第19章义大利癌症诊断市场

  • 义大利癌症诊断市场，依产品细分，实绩及预测，2018-2023年、2023-2028年，直至2033年
  • 义大利癌症诊断市场，按应用、实绩和预测细分，2018-2023 年、2023-2028 年，直至 2033 年
  • 义大利癌症诊断市场，按最终用户细分，实绩和预测，2018-2023年、2023-2028年，直至2033年

第20章西班牙癌症诊断市场

  • 西班牙癌症诊断市场，依产品细分，实绩及预测，2018-2023年、2023-2028年，直至2033年
  • 西班牙癌症诊断市场，按应用细分、实绩和预测，2018-2023、2023-2028、直至 2033 年
  • 西班牙癌症诊断市场，按最终用户细分，实绩和预测，2018-2023年、2023-2028年，直至2033年

第21章东欧癌症诊断市场

  • 东欧癌症诊断市场概况
  • 东欧癌症诊断市场，依产品、实绩及预测细分，2018-2023 年、2023-2028 年，至 2033 年
  • 东欧癌症诊断市场，按应用、实绩和预测细分，2018-2023 年、2023-2028 年，直至 2033 年
  • 东欧癌症诊断市场，按最终用户细分，实绩和预测，2018-2023 年、2023-2028 年，直至 2033 年

第22章俄罗斯癌症诊断市场

  • 俄罗斯癌症诊断市场，按产品、实绩和预测细分，2018-2023 年、2023-2028 年，直至 2033 年
  • 俄罗斯癌症诊断市场，按应用、实绩和预测细分，2018-2023年、2023-2028年，直至2033年
  • 俄罗斯癌症诊断市场，按最终用户细分，实绩和预测，2018-2023年、2023-2028年，直至2033年

第23章北美癌症诊断市场

  • 北美癌症诊断市场概况
  • 北美癌症诊断市场，按产品、实绩和预测细分，2018-2023 年、2023-2028 年，直至 2033 年
  • 北美癌症诊断市场，按应用、实绩和预测细分，2018-2023 年、2023-2028 年，直至 2033 年
  • 北美癌症诊断市场，按最终用户细分、实绩和预测，2018-2023 年、2023-2028 年，直至 2033 年

第24章美国癌症诊断市场

  • 美国癌症诊断市场概况
  • 美国癌症诊断市场，按产品细分、实绩和预测，2018-2023、2023-2028、直至 2033 年
  • 美国癌症诊断市场，按应用细分、实绩和预测，2018-2023、2023-2028、直至 2033 年
  • 美国癌症诊断市场，按最终用户细分，实绩和预测，2018-2023 年、2023-2028 年，直至 2033 年

第25章加拿大癌症诊断市场

  • 加拿大癌症诊断市场概况
  • 加拿大癌症诊断市场，按产品、实绩和预测细分，2018-2023、2023-2028、直至 2033 年
  • 加拿大癌症诊断市场，按应用细分、实绩和预测，2018-2023、2023-2028、直至 2033 年
  • 加拿大癌症诊断市场，按最终用户细分，实绩和预测，2018-2023 年、2023-2028 年、直至 2033 年

第26章南美洲癌症诊断市场

  • 南美洲癌症诊断市场概况
  • 南美癌症诊断市场，按产品细分、实绩和预测，2018-2023、2023-2028、直至 2033 年
  • 南美癌症诊断市场，按应用、实绩和预测细分，2018-2023、2023-2028、直至 2033 年
  • 南美癌症诊断市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、直至 2033 年

第27章巴西癌症诊断市场

  • 巴西癌症诊断市场，依产品、实绩及预测细分，2018-2023 年、2023-2028 年，至 2033 年
  • 巴西癌症诊断市场，按应用、实绩和预测细分，2018-2023 年、2023-2028 年，直至 2033 年
  • 巴西癌症诊断市场，按最终用户细分，实绩和预测，2018-2023 年、2023-2028 年，直至 2033 年

第28章中东癌症诊断市场

  • 中东癌症诊断市场概况
  • 中东癌症诊断市场，按产品、实绩和预测细分，2018-2023 年、2023-2028 年，直至 2033 年
  • 中东癌症诊断市场，按应用、实绩和预测细分，2018-2023、2023-2028、直至 2033 年
  • 中东癌症诊断市场，按最终用户细分，实绩和预测，2018-2023 年、2023-2028 年，直至 2033 年

第29章非洲癌症诊断市场

  • 非洲癌症诊断市场概况
  • 非洲癌症诊断市场，依产品、实绩及预测细分，2018-2023 年、2023-2028 年，至 2033 年
  • 非洲癌症诊断市场，按应用、实绩和预测细分，2018-2023 年、2023-2028 年，直至 2033 年
  • 非洲癌症诊断市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、直至 2033 年

第30章癌症诊断市场竞争形势及公司概况

  • 癌症诊断市场竞争形势
  • 癌症诊断市场的公司概况
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Hologic
    • GE Healthcare Ltd.
    • Thermo Fisher Scientific

第31章全球癌症诊断市场竞争基准化分析

第32章全球癌症诊断市场竞争仪表板

第33章癌症诊断市场重大併购

第34章癌症诊断市场未来展望及可能性分析

第35章附录

简介目录
Product Code: r8923

“Cancer Diagnostics Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The cancer diagnostics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Products: Companion Diagnostics; Molecular Diagnostics
  • 2) By Method: Biopsy; Endoscopy; Tumor Biomarker Tests; Imaging
  • 3) By Application: Cervical Cancer; Breast Cancer; Liver Cancer; Blood Cancer; Kidney Cancer; Colorectal Cancer; Pancreatic Cancer; Ovarian Cancer; Melanoma; Other Applications
  • 4) By End-User: Cancer Research Institutes; Diagnostic Laboratories; Hospitals; Other End Users
  • Companies Mentioned: Abbott Laboratories; Becton Dickinson and Company; Hologic; GE Healthcare Ltd.; Thermo Fisher Scientific
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Cancer diagnostic devices are specialized medical tools used for identifying and analyzing the stage and origins of the disease in patients by detecting specific oncogenic proteins and enzymes released by tumor cells.

The primary offerings within the cancer diagnostics sector include companion diagnostics and molecular diagnostics. Molecular diagnostics involve laboratory procedures to detect particular proteins, genes, or molecules indicating the presence of cancer. Diagnostic methods in cancer assessments encompass biopsies, endoscopies, tumor biomarker tests, and imaging. These diagnostic tools cater to various applications, including cervical cancer, breast cancer, liver cancer, blood cancer, kidney cancer, colorectal cancer, pancreatic cancer, ovarian cancer, melanoma, and others. They are utilized by diverse end-users like cancer research institutes, diagnostic laboratories, hospitals, and related entities.

The cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides cancer diagnostics market statistics, including cancer diagnostics industry global market size, regional shares, competitors with a cancer diagnostics market share, detailed cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the cancer diagnostics industry. This cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer diagnostics market size has grown rapidly in recent years. It will grow from $21.38 billion in 2023 to $23.84 billion in 2024 at a compound annual growth rate (CAGR) of 11.5%. Historical growth in the cancer diagnostic device sector can be linked to a rise in cancer occurrences, the implementation of cancer screening initiatives, the advancement of personalized medicine, and increased public awareness..

The cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $37.09 billion in 2028 at a compound annual growth rate (CAGR) of 11.7%. Anticipated growth in the upcoming period in the cancer diagnostic device industry can be linked to expanding markets, support from regulations, the integration of artificial intelligence (AI) and machine learning, and an increased emphasis on early detection and intervention. Notable trends predicted in this period involve liquid biopsies, comprehensive multi-omics approaches, point-of-care testing, and the execution of screening and early intervention campaigns.

The significant driver behind the cancer diagnostics market is the high prevalence of various cancer types, compelling a larger number of individuals to seek diagnosis and treatment. These escalating cancer incidents have led to cancer becoming the second most common cause of death globally, as per the World Health Organization (WHO). Projections by the National Cancer Institute (NCI) estimate new annual cancer cases to increase to 23.6 million by the year 2030.

The growth of the cancer diagnostic device market is anticipated to be significantly propelled by the rising incidence of lung cancer. Lung cancer, characterized by the uncontrolled growth of abnormal cells in lung tissues, is a prevalent and deadly form of cancer. Cancer diagnostic devices play a crucial role in detecting, diagnosing, and monitoring lung cancer, aiding healthcare professionals in identifying its presence, determining its type and stage, and guiding treatment strategies. For example, as of March 2023, Cancer.Net, an online resource affiliated with the American Society of Clinical Oncology (ASCO), has estimated that the United States will witness around 238,340 new cases of lung cancer in 2023, an increase from the 236,000 cases diagnosed in 2022. This escalating incidence of lung cancer is a key driver for the growth of the cancer diagnostic device market.

One of the significant limitations affecting the cancer diagnostics market is product recall. Product recall is a process implemented by companies to retrieve faulty or defective products sold or available in the market. When a product recall is initiated, the company incurs costs associated with rectifying or replacing the flawed products. In the cancer diagnostics sector, the expenses tied to the replacement of faulty devices can be notably high for manufacturers, leading to a restriction in market growth. A practical example is Siemens Healthcare Diagnostics' recall of its IMMULITE/IMMULITE 1000 Systems Prostate-Specific Antigen (PSA) Assay. The recall was due to the assay not meeting the anticipated high-dose hook effect, which hampered its effectiveness in detecting prostate cancer in conjunction with digital rectal examination (DRE) in men aged 50 years or older.

The emerging trend within the cancer diagnostics market is the utilization of AI-based systems for cancer detection. AI plays a pivotal role in enhancing the precision of image detection in diagnostic procedures related to breast and lung cancer. Its capabilities aid in identifying cancers during their early stages, thereby contributing to improved detection accuracy. In lung cancer screening, AI's involvement results in a reduction in false-positive occurrences, ultimately enhancing accuracy in cancer detection. Notably, researchers at the Naval Medical Center San Diego and Google AI research division developed an AI-driven solution for autonomous evaluation of lymph node biopsies, significantly enhancing metastatic breast cancer detection accuracy to 99%.

Prominent companies within the cancer diagnostic device market are directing their efforts toward technological advancements involving artificial intelligence (AI), as seen with QAi Prostate, to establish a competitive advantage in the industry. QAi Prostate is a cutting-edge cancer diagnostic tool specifically designed for prostate cancer detection. Notably, in March 2023, Qritive, a Singapore-based enterprise specializing in AI-powered diagnostic solutions for pathologists, introduced QAi Prostate. This innovative AI-driven tool employs machine learning algorithms to precisely recognize and categorize malignant and benign regions within prostate tissue samples. It serves as a valuable resource for pathologists, aiding in the accurate detection of prostate cancer while distinguishing between malignant and benign areas in the analyzed tissue samples.

The cancer diagnostics market is overseen by the FDA, which applies stringent regulations to cancer diagnostic devices like MRI and NMR. These devices fall under the Class II category due to their moderate associated risk. This classification subjects them to specific regulatory mandates encompassing performance standards, premarket data requirements, post-market surveillance, and necessary labelling conditions. Notably, device labelling must include details like contraindications, adverse reactions, precautions, warnings, and usage instructions. Such regulatory measures serve as a checkpoint for manufacturers producing cancer diagnostic devices.

Major companies operating in the cancer diagnostics market include Abbott Laboratories, Becton Dickinson and Company, Hologic, GE Healthcare Ltd., Thermo Fisher Scientific, Siemens Healthcare GmbH, Accuray, Elekta AB, C.R. BardInc., Biogenex Laboratories, Eckert & Ziegler BEBIG, Veracyte, PathAI, Bio-Rad Laboratories, Biochain, DiagnoCure, Illumina, Myriad Genetics, CompanionDx, Epic Sciences, Eli Lilly and Co, Genomic Health, Affymetrix, Agilent Technologies, Adaptive Biotechnologies, Biocartis, Biocept, Cancer Genetics Inc., Caris Life Sciences, Cepheid, Epigenomics AG, Exact Sciences, Foundation Medicine, GenMark Diagnostics, Guardant Health, HalioDX, IBA group, Invitae Corporation, Medtronic PLC, NanoString Technologies, Natera, NeoGenomics, Oncura Inc., PerkinElmer, Personal Genome Diagnostics, Qiagen, Roche Diagnostics, Theragenics Corporation, Varian Medical SystemsInc.

North America was the largest region in the cancer diagnostics market in 2023. Asia-Pacific was the second-largest region in the global cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The cancer diagnostics market consists of sales of pathology-based instruments (slide staining systems, tissue processing systems, cell processors, PCR instruments, NGS instruments, and other pathology-based instruments), imaging Instruments (CT systems, ultrasound systems, MRI systems, mammography systems, and nuclear imaging systems) and biopsy instruments that are used for the diagnosis of cancer. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Cancer Diagnostics Market Characteristics

3. Cancer Diagnostics Market Trends And Strategies

4. Cancer Diagnostics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Cancer Diagnostics Market Size and Growth

  • 5.1. Global Cancer Diagnostics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Cancer Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Cancer Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cancer Diagnostics Market Segmentation

  • 6.1. Global Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Companion Diagnostics
  • Molecule Diagnostics
  • 6.2. Global Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biopsy
  • Endoscopy
  • Tumor Biomarker Tests
  • Imaging
  • 6.3. Global Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cervical Cancer
  • Breast Cancer
  • Liver Cancer
  • Blood Cancer
  • Kidney Cancer
  • Colorectal Cancer
  • Pancreatic Cancer
  • Ovarian Cancer
  • Melanoma
  • Other Applications
  • 6.4. Global Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cancer Research Institutes
  • Diagnostic Laboratories
  • Hospitals
  • Other End Users

7. Cancer Diagnostics Market Regional And Country Analysis

  • 7.1. Global Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cancer Diagnostics Market

  • 8.1. Asia-Pacific Cancer Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cancer Diagnostics Market

  • 9.1. China Cancer Diagnostics Market Overview
  • 9.2. China Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cancer Diagnostics Market

  • 10.1. India Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cancer Diagnostics Market

  • 11.1. Japan Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cancer Diagnostics Market

  • 12.1. Australia Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cancer Diagnostics Market

  • 13.1. Indonesia Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cancer Diagnostics Market

  • 14.1. South Korea Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cancer Diagnostics Market

  • 15.1. Western Europe Cancer Diagnostics Market Overview
  • 15.2. Western Europe Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cancer Diagnostics Market

  • 16.1. UK Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cancer Diagnostics Market

  • 17.1. Germany Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cancer Diagnostics Market

  • 18.5. France Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cancer Diagnostics Market

  • 19.9. Italy Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cancer Diagnostics Market

  • 20.13. Spain Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cancer Diagnostics Market

  • 21.1. Eastern Europe Cancer Diagnostics Market Overview
  • 21.2. Eastern Europe Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cancer Diagnostics Market

  • 22.1. Russia Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cancer Diagnostics Market

  • 23.1. North America Cancer Diagnostics Market Overview
  • 23.2. North America Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cancer Diagnostics Market

  • 24.1. USA Cancer Diagnostics Market Overview
  • 24.2. USA Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cancer Diagnostics Market

  • 25.1. Canada Cancer Diagnostics Market Overview
  • 25.2. Canada Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cancer Diagnostics Market

  • 26.1. South America Cancer Diagnostics Market Overview
  • 26.2. South America Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cancer Diagnostics Market

  • 27.1. Brazil Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cancer Diagnostics Market

  • 28.1. Middle East Cancer Diagnostics Market Overview
  • 28.2. Middle East Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cancer Diagnostics Market

  • 29.1. Africa Cancer Diagnostics Market Overview
  • 29.2. Africa Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cancer Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Cancer Diagnostics Market Competitive Landscape
  • 30.2. Cancer Diagnostics Market Company Profiles
    • 30.2.1. Abbott Laboratories
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Becton Dickinson and Company
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Hologic
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. GE Healthcare Ltd.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Thermo Fisher Scientific
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Cancer Diagnostics Market Competitive Benchmarking

32. Global Cancer Diagnostics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Cancer Diagnostics Market

34. Cancer Diagnostics Market Future Outlook and Potential Analysis

  • 34.1 Cancer Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Cancer Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Cancer Diagnostics Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer